Mantovani A, Byrne CD, Scorletti E, Mantzoros CS, Targher G (2020) Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: an updated systematic review of randomized controlled trials
Our experienced health care professionals, including nurse practitioners and registered dietitians, create customized plans that address each patients unique medical history, lifestyle, and health conditions
MEDVi works by prescribing personalized GLP-1 medication to support weight loss goals
Sharma, N., Chaudhary, S
Pure Medical Spa provides only approved medications and does not offer retatrutide.
Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy Protocol number: AALL2131-NCT06124157 An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia Protocol number: AAML1831-NCT04293562 A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations
